Skip to main content
. 2017 Jul 26;18:39. doi: 10.1186/s12865-017-0222-z

Fig. 1.

Fig. 1

Vaccination schedules. CIGB-247 combinations using VSSP or aluminum phosphate as adjuvants were administered weekly (a) or bi-weekly (b), respectively. Pre-vaccination sampling included sera and plasma. After the end of the trial period (week 16), a re-immunization was done once every 4 weeks until death, intolerance, marked disease progression or patient’s withdrawal of consent